Exploring VION's Visionary Portfolio

Discover the companies transforming the life sciences landscape with innovative solutions in diagnostics, manufacturing, and research.

V (1)

Unified Vision

Our Unified Vision: Advancing Science and Technology

At VION Biosciences, our portfolio is built to empower innovation. By scaling, supporting, and expanding the VION Brand Portfolio, we enable groundbreaking solutions that drive global impact.

Driving Impact

001

VION Innovated Brand Portfolio

Bringing together trailblazers in biotechnology, diagnostics, and research.

002

Synergy & Growth

Facilitating collaboration and scalable solutions across our portfolio.

003

Global Impact

Transforming industries with high-quality products and services.

V (2)

VION Biosciences is driving breakthroughs across drug development, diagnostics, and therapeutic solutions.

Empowering
a World
of Discovery

Portfolio

Pioneering Companies in Our Portfolio

Meet the companies that make up VION Biosciences, each dedicated to reshaping the life sciences with innovation and excellence.

echelonbiosciences.com

Explore Echelon Biosciences

Leaders in lipid nanoparticles and assay development, driving advances in drug discovery.

Echelon Biosciences is committed to advancing lipid research and assay development, providing innovative solutions for drug discovery. Our cutting-edge technology supports researchers in unlocking new therapeutic pathways, accelerating scientific breakthroughs in the biomedical field.

aldon-chem.com

Explore Aldon

Experts in custom chemicals,
delivering critical solutions
for diagnostics and education.

With over 60 years of experience, Aldon offers diverse services, including private-label lab chemicals, chemical and life science contract manufacturing, and custom kitting solutions. Our Innovating Science® line provides over 500 educational kits, aligning theory with practice for students and educators. Committed to sustainability and safety, we collaborate closely with clients to deliver tailored solutions that meet specific requirements across various industries.

bioassaysys.com

Explore BioAssay Systems

BioAssay Systems develops and markets innovative, high-throughput assay solutions for life sciences research and drug discovery.

Since 2003, BioAssay Systems has been a trusted provider of assay kits and reagents, supporting researchers worldwide. Our extensive catalog includes over 250 products, covering areas such as blood and urine chemistry, metabolism, oncology, and more. We also offer custom assay development and lead discovery services, ensuring tailored solutions for unique research needs. Our commitment to quality and customer satisfaction has established us as a reliable partner in the scientific community.

anshlabs.com

Explore AnshLabs

Innovators in immunoassays, specializing in emerging biomarkers and diagnostic solutions.

Founded in 2010, Ansh Labs specializes in creating cutting-edge immunoassays that advance biomedical research in reproductive medicine, neurodegenerative disorders, oncology, and more. Our team of experts excels in developing assays from concept to fully validated products, ensuring high specificity and sensitivity. Serving life science researchers, hospitals, and commercial laboratories worldwide, we are committed to quality and customer satisfaction. In August 2024, Ansh Labs became part of the VION Biosciences family, further enhancing our capabilities and reach.

Difference

Driving Innovation Across Industries

What sets VION apart is our ability to empower breakthroughs across sectors with the VION Brand Portfolio and operational excellence.

img-2

01

End-to-End Solutions

Supporting every stage, from discovery to delivery.

img-6

02

Scalable Growth

Accelerating the impact of our portfolio companies.

03

Global Expertise

Bringing transformative products to market worldwide.

Empowering Breakthroughs

News

VION’s latest announcements, product launches, and milestones.

CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION Biosciences LLC (“VION Biosciences”), Iron Path Capital’s roll-up platform in the life science sector led by life science industry veteran, Mark Thornton.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proidentsunt.
V

Empowering
a World
of Discovery

Partner with VION Biosciences.

We’re always looking for innovative collaborators to help shape the future of life sciences.